An overview of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention.

CHIRPP: Canada's principal injury surveillance program. Canadian Hospitals Injury Reporting and Prevention Program. Inj Prev (1999) 2.92

Summary statement: appropriate medical care for the secondary school-aged athlete. J Athl Train (2008) 1.94

Atracurium--a post-marketing surveillance study: methods and U.S. experience. Br J Anaesth (1989) 1.17

Atracurium--a post-marketing surveillance study: U.K. study and discussion. Br J Anaesth (1989) 1.15

Evaluation of a bicycle helmet giveaway program--Texas, 1995. Pediatrics (1998) 0.98

Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders. J Steroid Biochem Mol Biol (1998) 0.89

Using communication theory in injury prevention campaigns. Inj Prev (2005) 0.84

RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. J Steroid Biochem Mol Biol (1994) 0.84

Acute hazardous materials release. Am J Public Health (1989) 0.81

Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogens in the rat: relation of their systemic activity to the formation of a common metabolite. J Steroid Biochem Mol Biol (1994) 0.77

National healthcare strategy in New Zealand. J Natl Med Assoc (2000) 0.75